Drug Profile
Meropenem - Pfizer/Sumitomo Pharma
Alternative Names: ICI 194660; ICI 213689; Mepem; Meronem; Meropen; Meropenem hydrate; Merozen; Merrem; Optinem; SM-7338; Zeropenem®Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Dainippon Sumitomo Pharma
- Developer Chiesi Farmaceutici; PENTA Foundation; Pfizer; Sanofi; Sumitomo Pharma
- Class Antibacterials; Pyrrolidines; Small molecules; Thienamycins
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Bacterial infections; Community-acquired pneumonia; Febrile neutropenia; Skin and soft tissue infections
- Discontinued Bacterial meningitis; Sepsis